Personal Dosimeter Market
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: ... Read More
Pertussis Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PERTUSSIS VACCINE INDUSTRY
2.1 Summary about Pertussis Vaccine Industry
2.2 Pertussis Vaccine Market Trends
2.2.1 Pertussis Vaccine Production & Consumption Trends
2.2.2 Pertussis Vaccine Demand Structure Trends
2.3 Pertussis Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Whole-cell vaccines
4.2.2 Acellular vaccines
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Whole-cell vaccines
5.2.2 Acellular vaccines
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Whole-cell vaccines
6.2.2 Acellular vaccines
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Whole-cell vaccines
7.2.2 Acellular vaccines
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Whole-cell vaccines
8.2.2 Acellular vaccines
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Whole-cell vaccines
9.2.2 Acellular vaccines
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi Pasteur
10.1.2 GSK
10.1.3 Mitsubishi Tanabe Pharma
10.1.4 Astellas Pharma
10.1.5 Minhai Biotechnology
10.1.6 Wuhan Institute of
10.1.7 Biological Products
10.1.8 Changchun Changsheng
10.1.9 Life Sciences
10.1.10 Beijing Tiantan
10.1.11 Biological Products
10.1.12 Chengdu Institute of
10.1.13 Biological Products
10.2 Pertussis Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi Pasteur
10.2.2 GSK
10.2.3 Mitsubishi Tanabe Pharma
10.2.4 Astellas Pharma
10.2.5 Minhai Biotechnology
10.2.6 Wuhan Institute of
10.2.7 Biological Products
10.2.8 Changchun Changsheng
10.2.9 Life Sciences
10.2.10 Beijing Tiantan
10.2.11 Biological Products
10.2.12 Chengdu Institute of
10.2.13 Biological Products
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table 1.Table Pertussis Vaccine Product Type Overview 2.Table Pertussis Vaccine Product Type Market Share List 3.Table Pertussis Vaccine Product Type of Major Players 4.Table Brief Introduction of Sanofi Pasteur 5.Table Brief Introduction of GSK 6.Table Brief Introduction of Mitsubishi Tanabe Pharma 7.Table Brief Introduction of Astellas Pharma 8.Table Brief Introduction of Minhai Biotechnology 9.Table Brief Introduction of Wuhan Institute of 10.Table Brief Introduction of Biological Products 11.Table Brief Introduction of Changchun Changsheng 12.Table Brief Introduction of Life Sciences 13.Table Brief Introduction of Beijing Tiantan 14.Table Brief Introduction of Biological Products 15.Table Brief Introduction of Chengdu Institute of 16.Table Brief Introduction of Biological Products 17.Table Products & Services of Sanofi Pasteur 18.Table Products & Services of GSK 19.Table Products & Services of Mitsubishi Tanabe Pharma 20.Table Products & Services of Astellas Pharma 21.Table Products & Services of Minhai Biotechnology 22.Table Products & Services of Wuhan Institute of 23.Table Products & Services of Biological Products 24.Table Products & Services of Changchun Changsheng 25.Table Products & Services of Life Sciences 26.Table Products & Services of Beijing Tiantan 27.Table Products & Services of Biological Products 28.Table Products & Services of Chengdu Institute of 29.Table Products & Services of Biological Products 30.Table Market Distribution of Major Players 31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 33.Table Global Pertussis Vaccine Market Forecast (Million USD) by Region 2021f-2026f 34.Table Global Pertussis Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f 35.Table Global Pertussis Vaccine Market Forecast (Million USD) by Demand 2021f-2026f 36.Table Global Pertussis Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure 1.Figure Global Pertussis Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Pertussis Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Pertussis Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Pertussis Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Pertussis Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Pertussis Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Pertussis Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 60.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 61.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 63.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 64.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 65.Figure Pertussis Vaccine Sales Revenue (Million USD) of Sanofi Pasteur 2017-2020e 66.Figure Pertussis Vaccine Sales Revenue (Million USD) of GSK 2017-2020e 67.Figure Pertussis Vaccine Sales Revenue (Million USD) of Mitsubishi Tanabe Pharma 2017-2020e 68.Figure Pertussis Vaccine Sales Revenue (Million USD) of Astellas Pharma 2017-2020e 69.Figure Pertussis Vaccine Sales Revenue (Million USD) of Minhai Biotechnology 2017-2020e 70.Figure Pertussis Vaccine Sales Revenue (Million USD) of Wuhan Institute of 2017-2020e 71.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e 72.Figure Pertussis Vaccine Sales Revenue (Million USD) of Changchun Changsheng 2017-2020e 73.Figure Pertussis Vaccine Sales Revenue (Million USD) of Life Sciences 2017-2020e 74.Figure Pertussis Vaccine Sales Revenue (Million USD) of Beijing Tiantan 2017-2020e 75.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e 76.Figure Pertussis Vaccine Sales Revenue (Million USD) of Chengdu Institute of 2017-2020e 77.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e 78.